SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-19-056493
Filing Date
2019-10-25
Accepted
2019-10-25 14:36:58
Documents
1
Group Members
MEDIMMUNE LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D a19-20977_1sc13d.htm SC 13D 224599
  Complete submission text file 0001104659-19-056493.txt   226431
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filed by) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009
Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 33430303030
Innate Pharma SA (Subject) CIK: 0001598599 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91173 | Film No.: 191169378
SIC: 2836 Biological Products, (No Diagnostic Substances)